Name: Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence (Video) | JoVE Journal
Uploaded: 2025-12-30T14:57:00.000+00:00
Duration: 4 min 56 s
Description: Learn multipoint Thioflavin T fluorescence detection of aggregation-prone mutant p53 V157F in breast cancer cells. This method improves accuracy for quantifying amyloid-like protein structures in cancer research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The authors gratefully acknowledge the technical assistance provided by the Basic Medical Core Laboratory at the College of Medicine, I-Shou University. This work was supported by grants from E-DA Hospital [EDAHJ114001 to C.-C.C.] and National Science and Technology Council, Taiwan [NSTC 112-2813-C-214-032-B to B.-H. C]

1. Cell seeding
<ol>
	<li>To assess cell viability, mix 10 µL of Trypan Blue with 10 µL of resuspended cells in 1x Dulbecco's Phosphate-Buffered Saline (DPBS) in a microcentrifuge tube and mix thoroughly.</li>
	<li>Load 10 µL of the mixture onto a counter slide, then count the live cells using an automated cell counter.</li>
	<li>Based on the viability count, seed 30,000 viable cells per well into a 96-well culture plate, with one well designated as a non-stained control and the remaining three wells used for staining.</li>
</ol>
2. Incubation
<ol>
	<li>Place the culture plate in a CO2 incubator and incubate 12 h at 37 °C.</li>
</ol>
3. Preparation of fresh ThT staining stock (1,000x)
<ol>
	<li>Weigh 0.02 g (20 mg) of ThT powder and dissolve it in 5.0 mL of deionized water. Mix thoroughly until the powder is completely dissolved. 
	NOTE: This preparation yields a 1,000x ThT stock solution with a final concentration of 4 mg/mL, equivalent to 12.5 mM (ThT has a molecular weight of ~318.85 g/mol. A solution of 4 mg/mL equals 4 g/L. Dividing 4 g/L by 318.85 g/mol gives 0.0125 mol/L, or ~12.5 mM).</li>
</ol>
4. Preparation of ThT staining buffer with nuclear counterstain
<ol>
	<li>Prepare the staining solution by adding the following to 1 mL of 1x DPBS and mix gently to ensure homogeneity.
	<ol>
		<li>Add 1 µL of freshly prepared 1,000x ThT stock, giving a final ThT concentration of 12.5 µM (1x).</li>
		<li>Add 1 µL of 1 mg/mL Hoechst 33342 stock solution, giving a final concentration of ~1 µg/mL (=1.6 µM).</li>
	</ol>
	</li>
</ol>
5. Staining
<ol>
	<li>Remove the culture medium from each well. Add 100 µL of the prepared ThT/Hoechst staining buffer to each staining well. Add 100 µL of 1x DPBS to non-stained control.</li>
</ol>
6. Incubation
<ol>
	<li>Place the plate in a dark place at room temperature (25 °C) for 30 min.</li>
</ol>
7. Washing
<ol>
	<li>Carefully aspirate or discard the staining solution from each well, taking care not to disturb the cell monolayer.</li>
	<li>Add 100 µL of 1× DPBS to each well and allow an optional gentle 30-second soak.</li>
	<li>Carefully aspirate or discard the DPBS wash solution.</li>
	<li>Repeat the wash by adding 100 µL of fresh 1x DPBS to each well, again allowing an optional 30-second gentle soak, then discard the DPBS wash solution.</li>
	<li>After the second wash, add 100 µL of fresh 1x DPBS to each well.</li>
</ol>
8. Fluorescence measurement
<ol>
	<li>Before reading the fluorescence signal, remove the cap from the 96-well plate. Measure fluorescence using one of two methods: single-point reading or four-point reading.</li>
	<li>Place the 96-well plate into a microplate reader, and measure fluorescence using the following settings: ThT fluorescence: Excitation at 450 nm, emission at 490 nm; Hoechst 33342 fluorescence: Excitation at 360 nm, emission at 460 nm; reader settings: Shaking: 5 s prior to reading; Read direction: Top read; Integration time: 140 ms; Read height: 1.00 mm; Points per well: 1 (endpoint) or 4 (well scan); Well scan setting: (Density setting: 2; Point spacing: 2.5).</li>
</ol>
9. Data analysis
<ol>
	<li>Calculate protein aggregation as follows: 
	<img alt="Aggregation signal formula, ThT and Hoechst OD, equation for amyloid aggregation analysis." src="/files/ftp_upload/68921/68921eq1.jpg" style="margin: auto;" data-altupdatedat="1783396841000" data-alt="Equation 1"></li>
	<li>Normalize ThT fluorescence intensity by setting the ratio in MCF7 cells as 1 (baseline control).</li>
</ol>

<ol><li>Binayke, A., Mishra, S., Suman, P., Das, S., Chander, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Awakening+the+%26%2334%3Bguardian+of+genome%26%2334%3B%3A+Reactivation+of+mutant+p53%5BTitle%5D)+AND+%22Cancer+Chemother+Pharmacol%22%5BJournal%5D)">Awakening the &#34;guardian of genome&#34;: Reactivation of mutant p53.</a> Cancer Chemother Pharmacol. 83 (1), 1-15 (2019).</li>
<li>Chen, C. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+simple+and+affordable+method+to+create+nonsense+mutation+clones+of+p53+for+studying+the+premature+termination+codon+readthrough+activity+of+ptc124%5BTitle%5D)+AND+%22Biomedicines%22%5BJournal%5D)">A simple and affordable method to create nonsense mutation clones of p53 for studying the premature termination codon readthrough activity of ptc124.</a> Biomedicines. 11 (5), 1310(2023).</li>
<li>Rangel, L. P., Costa, D. C., Vieira, T. C., Silva, J. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+aggregation+of+mutant+p53+produces+prion-like+properties+in+cancer%5BTitle%5D)+AND+%22Prion%22%5BJournal%5D)">The aggregation of mutant p53 produces prion-like properties in cancer.</a> Prion. 8 (1), 75-84 (2014).</li>
<li>Kim, S., An, S. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+p53+isoforms+and+aggregations+in+cancer%5BTitle%5D)+AND+%22Medicine+%28Baltimore%29%22%5BJournal%5D)">Role of p53 isoforms and aggregations in cancer.</a> Medicine (Baltimore). 95 (26), e3993(2016).</li>
<li>Zhou, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gain-of-function+mutant+p53+promotes+cell+growth+and+cancer+cell+metabolism+via+inhibition+of+ampk+activation%5BTitle%5D)+AND+%22Mol+Cell%22%5BJournal%5D)">Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of ampk activation.</a> Mol Cell. 54 (6), 960-974 (2014).</li>
<li>Zhang, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gain-of-function+mutant+p53+in+cancer+progression+and+therapy%5BTitle%5D)+AND+%22J+Mol+Cell+Biol%22%5BJournal%5D)">Gain-of-function mutant p53 in cancer progression and therapy.</a> J Mol Cell Biol. 12 (9), 674-687 (2020).</li>
<li>De Oliveira, G. aP., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+status+of+p53+oligomeric+and+aggregation+states+in+cancer%5BTitle%5D)+AND+%22Biomolecules%22%5BJournal%5D)">The status of p53 oligomeric and aggregation states in cancer.</a> Biomolecules. 10 (4), 548(2020).</li>
<li>Wang, H., Guo, M., Wei, H., Chen, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Targeting+p53+pathways%3A+Mechanisms%2C+structures%2C+and+advances+in+therapy%5BTitle%5D)+AND+%22Signal+Transduct+Target+Ther%22%5BJournal%5D)">Targeting p53 pathways: Mechanisms, structures, and advances in therapy.</a> Signal Transduct Target Ther. 8 (1), 92(2023).</li>
<li>Sulatskaya, A. I., Kuznetsova, I. M., Turoverov, K. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Interaction+of+thioflavin+t+with+amyloid+fibrils%3A+Stoichiometry+and+affinity+of+dye+binding%2C+absorption+spectra+of+bound+dye%5BTitle%5D)+AND+%22J+Phys+Chem+B%22%5BJournal%5D)">Interaction of thioflavin t with amyloid fibrils: Stoichiometry and affinity of dye binding, absorption spectra of bound dye.</a> J Phys Chem B. 115 (39), 11519-11524 (2011).</li>
<li>Cai, B. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Nampt+inhibitor+and+p73+activator+represses+p53+r175h+mutated+HNSCC+cell+proliferation+in+a+synergistic+manner%5BTitle%5D)+AND+%22Biomolecules%22%5BJournal%5D)">Nampt inhibitor and p73 activator represses p53 r175h mutated HNSCC cell proliferation in a synergistic manner.</a> Biomolecules. 12 (3), 438(2022).</li>
<li>Cai, B. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chlorophyllides+repress+gain-of-function+p53+mutated+hnscc+cell+proliferation+via+activation+of+p73+and+repression+of+p53+aggregation+in+vitro+and+in+vivo%5BTitle%5D)+AND+%22Biochim+Biophys+Acta+Mol+Basis+Dis%22%5BJournal%5D)">Chlorophyllides repress gain-of-function p53 mutated hnscc cell proliferation via activation of p73 and repression of p53 aggregation in vitro and in vivo.</a> Biochim Biophys Acta Mol Basis Dis. 1871 (3), 167662(2025).</li>
<li>Wu, K. -Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Synergistic+anticancer+activity+of+hsp70+inhibitor+and+doxorubicin+in+gain-of-function+mutated+p53+breast+cancer+cells%5BTitle%5D)+AND+%22Biomedicines%22%5BJournal%5D)">Synergistic anticancer activity of hsp70 inhibitor and doxorubicin in gain-of-function mutated p53 breast cancer cells.</a> Biomedicines. 13 (5), 1034(2025).</li>
<li>Nasir, I., Linse, S., Cabaleiro-Lago, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fluorescent+filter-trap+assay+for+amyloid+fibril+formation+kinetics+in+complex+solutions%5BTitle%5D)+AND+%22ACS+Chem+Neurosci%22%5BJournal%5D)">Fluorescent filter-trap assay for amyloid fibril formation kinetics in complex solutions.</a> ACS Chem Neurosci. 6 (8), 1436-1444 (2015).</li>
<li>Goldsbury, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Amyloid+structure+and+assembly%3A+Insights+from+scanning+transmission+electron+microscopy%5BTitle%5D)+AND+%22J+Struct+Biol%22%5BJournal%5D)">Amyloid structure and assembly: Insights from scanning transmission electron microscopy.</a> J Struct Biol. 173 (1), 1-13 (2011).</li>
<li>Kayed, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fibril+specific%2C+conformation+dependent+antibodies+recognize+a+generic+epitope+common+to+amyloid+fibrils+and+fibrillar+oligomers+that+is+absent+in+prefibrillar+oligomers%5BTitle%5D)+AND+%22Mol+Neurodegener%22%5BJournal%5D)">Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.</a> Mol Neurodegener. 2, 18(2007).</li>
<li>Xue, C., Lin, T. Y., Chang, D., Guo, Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Thioflavin+t+as+an+amyloid+dye%3A+Fibril+quantification%2C+optimal+concentration+and+effect+on+aggregation%5BTitle%5D)+AND+%22R+Soc+Open+Sci%22%5BJournal%5D)">Thioflavin t as an amyloid dye: Fibril quantification, optimal concentration and effect on aggregation.</a> R Soc Open Sci. 4 (1), 160696(2017).</li>
<li>Biancalana, M., Koide, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Molecular+mechanism+of+thioflavin-t+binding+to+amyloid+fibrils%5BTitle%5D)+AND+%22Biochim+Biophys+Acta%22%5BJournal%5D)">Molecular mechanism of thioflavin-t binding to amyloid fibrils.</a> Biochim Biophys Acta. 1804 (7), 1405-1412 (2010).</li>
<li>Yang-Hartwich, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((P53+protein+aggregation+promotes+platinum+resistance+in+ovarian+cancer%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">P53 protein aggregation promotes platinum resistance in ovarian cancer.</a> Oncogene. 34 (27), 3605-3616 (2015).</li>
<li>Lei, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Insights+into+allosteric+mechanisms+of+the+lung-enriched+p53+mutants+v157f+and+r158l%5BTitle%5D)+AND+%22Int+J+Mol+Sci%22%5BJournal%5D)">Insights into allosteric mechanisms of the lung-enriched p53 mutants v157f and r158l.</a> Int J Mol Sci. 23 (17), 10100(2022).</li>
<li>Reichard, A., Asosingh, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Best+practices+for+preparing+a+single+cell+suspension+from+solid+tissues+for+flow+cytometry%5BTitle%5D)+AND+%22Cytometry+A%22%5BJournal%5D)">Best practices for preparing a single cell suspension from solid tissues for flow cytometry.</a> Cytometry A. 95 (2), 219-226 (2019).</li>
<li>Mansoury, M., Hamed, M., Karmustaji, R., Al Hannan, F., Safrany, S. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+edge+effect%3A+A+global+problem.+The+trouble+with+culturing+cells+in+96-well+plates%5BTitle%5D)+AND+%22Biochem+Biophys+Rep%22%5BJournal%5D)">The edge effect: A global problem. The trouble with culturing cells in 96-well plates.</a> Biochem Biophys Rep. 26, 100987(2021).</li>
<li>Yoshimura, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Distinguishing+crystal-like+amyloid+fibrils+and+glass-like+amorphous+aggregates+from+their+kinetics+of+formation%5BTitle%5D)+AND+%22Proc+Natl+Acad+Sci+U+S+A%22%5BJournal%5D)">Distinguishing crystal-like amyloid fibrils and glass-like amorphous aggregates from their kinetics of formation.</a> Proc Natl Acad Sci U S A. 109 (36), 14446-14451 (2012).</li>
<li>Yang, D. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mesoscopic+protein-rich+clusters+host+the+nucleation+of+mutant+p53+amyloid+fibrils%5BTitle%5D)+AND+%22Proc+Natl+Acad+Sci+U+S+A%22%5BJournal%5D)">Mesoscopic protein-rich clusters host the nucleation of mutant p53 amyloid fibrils.</a> Proc Natl Acad Sci U S A. 118 (10), e2015618118(2021).</li>
<li>Hackl, E. V., Darkwah, J., Smith, G., Ermolina, I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Effect+of+acidic+and+basic+ph+on+thioflavin+t+absorbance+and+fluorescence%5BTitle%5D)+AND+%22Eur+Biophys+J%22%5BJournal%5D)">Effect of acidic and basic ph on thioflavin t absorbance and fluorescence.</a> Eur Biophys J. 44 (4), 249-261 (2015).</li>
<li>Bom, A. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+p53+core+domain+is+a+molten+globule+at+low+ph%3A+Functional+implications+of+a+partially+unfolded+structure%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">The p53 core domain is a molten globule at low ph: Functional implications of a partially unfolded structure.</a> J Biol Chem. 285 (4), 2857-2866 (2010).</li>
<li>Ano Bom, A. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mutant+p53+aggregates+into+prion-like+amyloid+oligomers+and+fibrils%3A+Implications+for+cancer%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: Implications for cancer.</a> J Biol Chem. 287 (33), 28152-28162 (2012).</li>
<li>Muller, P., Ceskova, P., Vojtesek, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hsp90+is+essential+for+restoring+cellular+functions+of+temperature-sensitive+p53+mutant+protein+but+not+for+stabilization+and+activation+of+wild-type+p53%3A+Implications+for+cancer+therapy%5BTitle%5D)+AND+%22J+Biol+Chem%22%5BJournal%5D)">Hsp90 is essential for restoring cellular functions of temperature-sensitive p53 mutant protein but not for stabilization and activation of wild-type p53: Implications for cancer therapy.</a> J Biol Chem. 280 (8), 6682-6691 (2005).</li>
<li>Arsic, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((%CE%94133p53%CE%B2+isoform+pro-invasive+activity+is+regulated+through+an+aggregation-dependent+mechanism+in+cancer+cells%5BTitle%5D)+AND+%22Nat+Commun%22%5BJournal%5D)">Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells.</a> Nat Commun. 12 (1), 5463(2021).</li>
<li>Zhao, L., Punga, T., Sanyal, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Delta133p53alpha+and+delta160p53alpha+isoforms+of+the+tumor+suppressor+protein+p53+exert+dominant-negative+effect+primarily+by+co-aggregation%5BTitle%5D)+AND+%22Elife%22%5BJournal%5D)">Delta133p53alpha and delta160p53alpha isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation.</a> Elife. 14, RP106469(2025).</li>
</ol>

The authors have no conflicts of interest to declare.

When seeding cells into 96-well plates, it is often difficult to achieve uniform distribution across the well surface, as gently shaking or tapping the plate to spread the cells is not always feasible. This uneven distribution can introduce variability in signal intensity across the well. Multipoint fluorescence reading revealed significant variation between different regions within the same well, highlighting this bias and the potential for misleading results when only a single point is measured. Relying on a single cen...

The TP53 gene, which encodes the tumor suppressor protein p53, is mutated in approximately 50% of human cancers1,2. Such mutations not only abolish the tumor-suppressive functions of p53 but, in certain hotspot variants, also promote the formation of prion-like aggregates3,4. These aggregated forms of mutant p53 frequently acquire gain-of-function properties, including increased resistance to anticancer therapies5,6. Therefore, identifying which p53 hotspot mutations are prone to aggregation is critical for guiding the development of effective treatment strategies in p53-mutant cancers7,8.
In our previous studies, we observed that specific p53 mutations in head and neck squamous cell carcinoma (HNSCC) and breast cancer cell lines exhibit strong Thioflavin T (ThT) staining signals, indicating the presence of aggregated proteins. ThT is a benzothiazole dye that specifically binds to &#946;-sheet-rich amyloid structures, producing enhanced fluorescence upon binding9. For example, the Detroit 562 HNSCC cell line, which carries the p53 R175H mutation, exhibited strong ThT fluorescence signals10. Similarly, two other HNSCC cell lines, TW01 and HONE-1, both harboring the p53 R280T mutation, also showed pronounced ThT staining11. In these cases, ThT signals colocalized with p53, supporting the presence of aggregated p5310,11.
In breast cancer cells, MDA-MB-231 (p53 R280K mutation) and T47D (p53 L194F mutation) likewise displayed strong ThT staining with clear p53/ThT co-localization12. By contrast, MCF7 cells, which express wild-type p53, and MDA-MB-468 cells (p53 R273H mutation) both showed only weak ThT signals12. Similarly, OECM-1 HNSCC cells with the p53 V173L mutation demonstrated low levels of ThT staining10.
Compared with other protein aggregation detection methods-such as filter trap assays, transmission electron microscopy (TEM), or immunostaining with aggregate-specific antibodies-ThT fluorescence analysis offers several advantages. It is non-destructive, rapid, and applicable to both live and fixed cells without extensive processing. While filter trap assays effectively capture insoluble aggregates, they require harsh denaturation and are unsuitable for live-cell use13. TEM provides direct visualization of fibril morphology but is labor-intensive and low-throughput14. Aggregate-specific immunostaining enables in situ detection using conformation-dependent antibodies, though antibody availability and specificity can be limiting15. In contrast, ThT fluorescence-especially when combined with multipoint plate reading-offers a simple, quantitative, and spatially reliable approach for detecting &#946;-sheet-rich or amyloid-like structures.
Practical considerations are also key for reproducibility. ThT fluorescence correlates linearly with amyloid concentration across a wide concentration range (0.2-500 &#181;M), and peak signal is typically achieved at 20-50 &#181;M, depending on the protein-though ThT self-fluorescence can emerge at &#8805;5 &#181;M, and higher concentrations may impact aggregation kinetics16. Therefore, a working ThT concentration around 10-20 &#181;M is generally recommended to balance sensitivity while minimizing potential effects on aggregation processes16. In our protocol, the 1,000x ThT stock (12. mM) is diluted 1:1,000 to yield a working concentration of approximately 12. &#181;M, which falls within this recommended range.
ThT preferentially binds to &#946;-sheet-rich amyloid structures, which are characteristic of amyloid fibrils. This specificity arises from the dye&#39;s interaction with the cross-&#946; architecture of amyloid fibrils, where the surfaces formed by &#946;-strands provide binding sites for ThT. Consequently, ThT may not effectively detect other misfolded or non-amyloid aggregates that do not exhibit this &#946;-sheet-rich structure17. Therefore, while ThT is a valuable tool for identifying amyloid fibrils, it is advisable to employ complementary validation methods-such as co-localization with p53 immunofluorescence or biophysical approaches-to verify the identity and specificity of the aggregates detected10,18.
Structural prediction studies suggest that the p53 V157F mutation adopts a conformation more prone to aggregation than the wild-type protein19. In this study, we compared ThT fluorescence signals between Hs578T breast cancer cells, which harbor the aggregation-prone p53 V157F mutation, and MCF7 breast cancer cells expressing wild-type p53. Using a multipoint plate reader-based ThT staining assay, we sought to assess the aggregation propensity of p53 V157F relative to wild-type p53.

<table><tbody><tr><td>96-well culture plate</td><td>Simply</td><td>PC396-0100</td><td></td></tr><tr><td>counter slide</td><td>Invitrogen</td><td>C10228</td><td></td></tr><tr><td>Countess II FL Automated Cell Counter</td><td>Thermo Fisher Scientific&amp;nbsp;</td><td>AMQAF1000</td><td></td></tr><tr><td>dPBS</td><td>Simply</td><td>CC704-0500</td><td></td></tr><tr><td>Eppendorf tube</td><td>Simply</td><td>PC101-5000</td><td></td></tr><tr><td>Hoechst 33342</td><td>AAT Bioquest</td><td>17530</td><td></td></tr><tr><td>SpectraMax iD3</td><td>Molecular Devices</td><td>735-0391&amp;nbsp;</td><td></td></tr><tr><td>Thioflavin T</td><td>Sigma-Aldrich</td><td>T3516</td><td></td></tr><tr><td>Trypan Blue</td><td>Invitrogen</td><td>T10282</td><td></td></tr></tbody></table>

detection of aggregation-prone behavior in mutant p53 v157f breast cancer cells using multipoint thioflavin t fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

The tumor suppressor p53, encoded by the TP53 gene, plays a central role in maintaining genomic stability. TP53 mutations, particularly hotspot variants, are found in approximately 50% of human cancers and may lead to the loss of tumor-suppressive functions or the acquisition of gain-of-function properties, including aggregation into prion-like structures.
In this study, we assessed the aggregation tendency of the p53 V157F mutation in Hs578T breast cancer cells compared to MCF7 cells expressing wild-type p53. Protein aggregation was evaluated using Thioflavin T (ThT) staining followed by fluorescence quantification in 96-well plate assays. Cells were stained with a ThT/Hoechst solution, washed, and analyzed using a microplate reader under defined excitation/emission parameters. Quantitative analysis using both single-point and four-point fluorescence readings revealed that Hs578T cells exhibited a 3.20- to 4.26-fold increase in ThT fluorescence intensity relative to MCF7, indicating significantly elevated levels of &#946;-sheet-rich or amyloid-like aggregates. Multipoint measurements confirmed the widespread and consistent presence of protein aggregates across the well surface. These findings support the use of multipoint plate-reading to accurately detect protein aggregation in cell-based assays.

To investigate the presence of β-sheet-rich protein aggregates in breast cancer cells, MCF7 and Hs578T cell lines were subjected to ThT staining followed by fluorescence quantification. As shown in Figure 1, cells were seeded into four wells of a 96-well plate, with one well designated as an unstained control. The remaining three wells were stained with ThT according to the standard protocol. Fluorescence was measured using two approaches: (1) a single-point reading taken from the center of ...

Hs578T breast cancer cells harboring the p53 V157F mutation exhibit significantly higher Thioflavin T fluorescence compared to MCF7 cells, indicating enhanced protein aggregation. Multipoint fluorescence measurements improve detection accuracy and reliability in identifying &#946;-sheet-rich aggregates, underscoring the importance of aggregation-prone p53 mutations in cancer research and the development of therapeutic strategies.

The tumor suppressor p53, encoded by the TP53 gene, plays a central role in maintaining genomic stability. TP53 mutations, particularly hotspot variants, ...

This study examines the aggregation propensity of mutant p53 V157F in breast cancer cells and evaluates multi-point plate reading for detection. Current experimental challenges include accurately detecting p53 aggregation, quantifying amyloid like structures, and ensuring consistent measurement across cell-based assay surfaces. To begin, take 10 microliters of trypan blue in a micro centrifuge tube.Add 10 microliters of resuspended cells in DPBS to the same tube and mix the contents thoroughly to ensure homogeneity. Load 10 microliters of the prepared mixture onto a counter slide to count the live cells using an automated cell counter. Based on the viability count, seed 30, 000 viable cells per well into a 96 well culture plate.Designate one well as a non-stained control and designate the remaining three wells for staining. Weigh 0.02 grams of Thioflavin T or THT powder using a balance. Add the powder to five milliliters of deionized water and mix thoroughly until the powder is completely dissolved.Then add the staining components to one milliliter of DPBS. Add THT and Hoechst stock solutions to the tube and mix gently to ensure homogeneity. Now remove the culture medium from each well of the 96 well culture plate.Add 100 microliters of the prepared THT and Hoechst staining buffer to each staining well followed by 100 microliters of DPBS to the non-stained control well. Place the culture plate in a dark place at room temperature for 30 minutes. Carefully aspirate or discard the staining solution from each well without disturbing the cell monolayer.Then add 100 microliters of DPBS to each well and leave it for 30 seconds. Then discard the DPB. After repeating the washing step, add 100 microliters of fresh DPBS to each well.Remove the cap from the 96 well culture plate before reading the fluorescent signal. Place the 96 well culture plate into the microplate reader. Measure THT fluorescence with excitation at 450 nanometers and a mission at 490 nanometers and measure Hoechst 33342 fluorescence with excitation at 360 nanometers and a mission at 460 nanometers.Select the desired read area and then set the reader parameters, including shaking for five seconds before reading top redirection and an integration time of 140 milliseconds. After acquiring the fluorescence data, perform calculations to obtain the protein aggregation values. Finally normalize the THT fluorescence intensity by setting the ratio in MCF7 cells as one to serve as the baseline control Measurements were performed using both a single point and a four point method across stained and non-stained wells in MCF7 and Hs578T cells.Hs578T breast cancer cells showed a 3.2 fold increase in thioflavin T fluorescence intensity compared to MCF7 cells using the single point reading method. When using the four point average reading method, Hs578T cells exhibited a 3.86 fold increase in thioflavin T fluorescence compared to MCF7 cells. Thioflavin T fluorescence in Hs578T cells was consistently elevated at all four measurement points compared to MCF7 cells.This protocol enables accurate protein aggregation detection in cellular contexts using thioflavin T staining, combined with reliable multi-point fluorescence plate reading methods.

detection-aggregation-prone-behavior-mutant-p53-v157f-breast-cancer

Research

JoVE Journal

Cancer Research

In this video, we demonstrate a cell-based protein aggregation assay using proteasome inhibitors, which block proteasome activity, preventing misfolded, mutant proteins, fused to a fluorescent label, from undergoing ubiquitin-dependent proteasomal degradation, leading to their accumulation within the cell cytoplasm. The protein aggregates are then visualized and quantified by fluorescence microscopy.

Protein Aggregate Formation Assay: A Method to Detect and Quantify Protein Aggregation in Cultured Cells upon Induction by Proteasome Inhibitor

This video demonstrates imaging and quantification of protein aggregates in genetically modified Drosophila brains. Brains are fixed, washed, and treated with an antifading agent before mounting. Images are captured using a confocal microscope and quantified to observe the transmission of mutant protein aggregates.

Imaging and Quantification of Protein Aggregates in Genetically Modified Drosophila Brains

Unmodified and hyperphosphorylated tau proteins were used in two in vitro aggregation assays to reveal the hyperphosphorylation-dependent fast aggregation kinetics. These assays pave the way for future screens for compounds that can modulate the propensity of hyperphosphorylated tau to form fibrils that underlie the progression of Alzheimer’s disease.

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Cell-to-cell transfer of protein aggregates, or proteopathic seeds, may underlie the progression of pathology in neurodegenerative diseases. Here, a novel FRET flow cytometry assay is described that enables specific and sensitive detection of seeding activity from recombinant or biological samples.

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry

Here, it is demonstrated how the in situ Proximity Ligation Assay (PLA) can be used to detect and visualize the direct protein-protein interactions between ATM and p53 in suspension cell cultures exposed to genotoxic stress.

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay

A capillary-based immunoassay using a commercial platform to measure target proteins from total protein preparations is demonstrated. In addition, assay parameters of exposure time, protein concentration, and antibody dilution are optimized for a cell culture model system.

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Accumulating evidence supports the idea that pathogenic protein aggregates associated with neurodegenerative diseases spread between cells with prion-like properties. Here, we describe a method that enables visualization of cell-to-cell spreading of prion-like aggregates in the model organism, Drosophila melanogaster.

Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster

Here we present a novel method for determining binding affinities at equilibrium and in solution with high sensitivity on a large scale. This improves the quantitative analysis of transcription factor-DNA binding. The method is based on automated fluorescence anisotropy measurements in a controlled delivery system.

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Presented here are four protocols to construct and exploit yeast Saccharomyces cerevisiae reporter strains to study human P53 transactivation potential, impacts of its various cancer-associated mutations, co-expressed interacting proteins, and the effects of specific small molecules.

Yeast As a Chassis for Developing Functional Assays to Study Human P53

We present a freely available workflow built for rapid exploration and accurate analysis of cellular bodies in specific cell compartments in fluorescence microscopy images. This user-friendly workflow is designed on the open-source software Icy and also uses ImageJ functionalities. The pipeline is affordable without knowledge in image analysis.

Substructure Analyzer: A User-Friendly Workflow for Rapid Exploration and Accurate Analysis of Cellular Bodies in Fluorescence Microscopy Images

Here, we present a protocol for improving the success of interphase fluorescence in situ hybridization detection on bone marrow smears from multiple myeloma patients.

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Learn multipoint Thioflavin T fluorescence detection of aggregation-prone mutant p53 V157F in breast cancer cells. This method improves accuracy for quantifying amyloid-like protein structures in cancer research.

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Explore More Videos